Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Escherichia coli heat-labile enterotoxin B subunit is one of five identical binding subunits forming the pentameric ring of the heat-labile AB5 enterotoxin. This subunit is responsible for the high-affinity binding of the toxin complex to GM1 gangliosides on the surface of mammalian cells, enabling entry of the enzymatically active A subunit. The B subunit has no enzymatic activity but is essential for pathogenesis, as well as for its potent capacity to serve as a research and clinical adjuvant. Recombinant LT-B, lacking the toxic activity of the A subunit, is being explored for its ability to modulate immune responses, induce regulatory T cells, and act as a carrier or platform for antigens in vaccines. Its structure and function are closely related to the cholera toxin B subunit, but it has antigenic distinctions and unique binding properties.
Binds GM1 ganglioside receptors in host cell membranes, allowing uptake of the whole AB5 toxin complex. When used as an adjuvant or delivery tool, facilitates antigen uptake and T cell activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli heat-labile enterotoxin B subunit (LT-B).